B cell activation during viral infection
病毒感染期间 B 细胞激活
基本信息
- 批准号:7246733
- 负责人:
- 金额:$ 40.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-15 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntibody FormationAntigensApoptoticAutoantigensAutoimmune DiseasesB-Cell ActivationB-LymphocytesCD4 Positive T LymphocytesCellsCellular ImmunityClassCytolysisDataDevelopmentDiabetes MellitusEventGoalsHistocompatibility Antigens Class IIHomeostasisHumoral ImmunitiesImmune responseImmune systemImmunityInfectionInfection ControlLightLupusLymphocyteMediatingMemoryMemory LossNatureProliferatingResistanceRoleSpecificityT memory cellT-LymphocyteThinkingVaccinationVaccine DesignViralViral AntigensViral PathogenesisVirusVirus Diseasescell killingcofactorimmunoglobulin receptorin vivokillingslymphocyte proliferationpathogenprogramsresponse
项目摘要
DESCRIPTION (provided by applicant): Viral infections are controlled by immune responses associated with the induction of cellular immunity mediated by T lymphocytes, which kill virus-infected targets and control viral synthesis, and of humoral immunity mediated by B lymphocytes, which produce antibodies that inactivate viruses. The presence of long lasting antibody responses is important to maintain resistance to re- infection and is a goal of vaccine design. Studies on immune system activation and homeostasis have shown, however, that one should not think of immune responses to pathogens as isolated independent events, but instead as part of a continuum within an immune system modulated by memory lymphocyte pools specific to previously encountered pathogens. Prior T cell responses influence the nature of T cell responses to newly encountered pathogens, and newly encountered pathogens alter the homeostasis of memory T cell pools specific to previously encountered pathogens. This modulation of T cell responses can alter viral pathogenesis and is a component of what we refer to as heterologous immunity, but heterologous immunity has not been systematically investigated for B cell-dependent antibody responses. In fact, viral infections can enhance antibody responses to previously encountered viruses and sometimes to auto (self) antigens, including those associated with experimental autoimmune diseases like diabetes and lupus erythematosis. Our recent data have demonstrated profound influences in vivo of virus-specific CD4 T cells on B cells presenting viral antigens on their class II molecules, regardless of the B cell immunoglobulin receptor (BCR) specificity. Some of these B cells are lysed by CD4 T cells, whereas others are induced to polyclonally proliferate and differentiate. Here we propose to examine the phenomenon of BCR-independent polyclonal B cell activation and the influence of heterologous viral infections on the homeostasis of humoral immunity. Understanding how humoral immunity is maintained will shed light on strategies for the development of long term protective vaccination-induced antibody responses.
描述(由申请人提供):病毒感染是通过与 T 淋巴细胞介导的细胞免疫(杀死病毒感染的靶标并控制病毒合成)和 B 淋巴细胞介导的体液免疫(产生抗体)相关的免疫反应来控制的。灭活病毒。持久抗体反应的存在对于维持对再次感染的抵抗力很重要,并且是疫苗设计的目标。然而,关于免疫系统激活和稳态的研究表明,人们不应将对病原体的免疫反应视为孤立的独立事件,而应将其视为免疫系统内连续体的一部分,该免疫系统由针对先前遇到的病原体的记忆淋巴细胞池调节。先前的 T 细胞反应会影响 T 细胞对新遇到的病原体的反应性质,而新遇到的病原体会改变针对先前遇到的病原体的记忆 T 细胞池的稳态。 T 细胞反应的这种调节可以改变病毒的发病机制,并且是我们所说的异源免疫的一个组成部分,但异源免疫尚未针对 B 细胞依赖性抗体反应进行系统研究。事实上,病毒感染可以增强对先前遇到的病毒的抗体反应,有时还可以增强对自身抗原的抗体反应,包括与糖尿病和红斑狼疮等实验性自身免疫性疾病相关的抗体反应。我们最近的数据表明,无论 B 细胞免疫球蛋白受体 (BCR) 特异性如何,体内病毒特异性 CD4 T 细胞对在其 II 类分子上呈递病毒抗原的 B 细胞都有深远的影响。其中一些 B 细胞被 CD4 T 细胞裂解,而另一些则被诱导多克隆增殖和分化。在这里,我们建议研究BCR独立的多克隆B细胞激活现象以及异源病毒感染对体液免疫稳态的影响。了解体液免疫是如何维持的将有助于揭示长期保护性疫苗接种诱导抗体反应的发展策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raymond M Welsh其他文献
Raymond M Welsh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raymond M Welsh', 18)}}的其他基金
CD4 T cells in anti-viral immunity and immune pathology
CD4 T 细胞在抗病毒免疫和免疫病理学中的作用
- 批准号:
8652531 - 财政年份:2014
- 资助金额:
$ 40.63万 - 项目类别:
NK cell regulation of CD4 T cell responses
NK 细胞对 CD4 T 细胞反应的调节
- 批准号:
9226027 - 财政年份:2014
- 资助金额:
$ 40.63万 - 项目类别:
CD4 T cells in anti-viral immunity and immune pathology
CD4 T 细胞在抗病毒免疫和免疫病理学中的作用
- 批准号:
9443502 - 财政年份:2014
- 资助金额:
$ 40.63万 - 项目类别:
Effect of Virus Infections on the Maintenance of Transplantation Tolerance
病毒感染对移植耐受维持的影响
- 批准号:
8279392 - 财政年份:2011
- 资助金额:
$ 40.63万 - 项目类别:
Effect of Virus Infections on the Maintenance of Transplantation Tolerance
病毒感染对移植耐受维持的影响
- 批准号:
7994917 - 财政年份:2010
- 资助金额:
$ 40.63万 - 项目类别:
Recombinant Vaccinia Virus with Reduced Virulence
毒力降低的重组痘苗病毒
- 批准号:
7698922 - 财政年份:2008
- 资助金额:
$ 40.63万 - 项目类别:
相似国自然基金
Tfh细胞调节自身抗体形成在溃疡性结肠炎体液免疫应答中的作用
- 批准号:81170361
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
胞内化抗体介导的HBcAg去功能化抑制HBV核壳体形成的机制研究
- 批准号:81070335
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
老年性和致病性II型胶原位点自身抗体形成机理探讨
- 批准号:39870857
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
流体力学的指標に着目した心房細動における血栓形成の原因解明と抗凝固療法指標の構築
阐明房颤血栓形成原因并制定以水动力指标为重点的抗凝治疗指标
- 批准号:
24K19060 - 财政年份:2024
- 资助金额:
$ 40.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice
表征下一代免疫人源化小鼠对 HIV-1 疫苗接种的抗体反应
- 批准号:
10673292 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein
用于输送呼吸道合胞病毒预融合蛋白的自我辅助颗粒系统的优化
- 批准号:
10666079 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 40.63万 - 项目类别: